This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gopala Krishna Jarugumilli: Inventor in TEAD Transcription Factor Research
Introduction
Gopala Krishna Jarugumilli is an inventor based in Malden, Massachusetts. His patent work concerns compounds designed to inhibit TEAD transcription factors, which are associated with cancer and other diseases.
Latest Patents
Jarugumilli is associated with 1 patent: “Small Molecule Inhibitors of TEAD Transcription Factors.” The disclosure describes compounds, compositions, and methods of use intended to inhibit TEAD transcription factor activity. The proposed applications include treating diseases related to TEAD activity, such as cancer.
Career Highlights
Jarugumilli is associated with The General Hospital Corporation. His patent work reflects research into small-molecule approaches for modulating transcription factor activity.
Collaborations
His listed coworkers include Krishna Chaitanya Talluri and Sunil Kumar Panigrahi. Their shared association connects them to research and patent activity involving TEAD inhibitors.
Conclusion
Gopala Krishna Jarugumilli’s patent contribution focuses on TEAD-inhibiting compounds and their potential use in treating cancer and other related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile